|
Market Closed -
Japan Exchange
02:30:00 2026-08-13 EDT
|
5-day change | 1st Jan Change | ||
| 2,327.50 JPY | -1.21% |
|
+7.80% | +11.20% |
| 08-10 | AbCellera's menopause drug cuts hot flashes in mid-stage trial, shares surge | RE |
| 08-05 | Japan Earnings Wrap: Kao, Astellas Pharma Rise; Taiyo Yuden Declines | MT |
"Total Return" performance includes dividend payments over the period, as if they were reinvested at 100%.
The annotated values (TR) are displayed with their "Total Return" performance (only if available).
End-of-day quotes
The annotated values (TR) are displayed with their "Total Return" performance (only if available).
End-of-day quotes
Sector Other Pharmaceuticals
| Capi. | Sales Growth | Profitability | Finances | EV / Sales | P/E | |
|---|---|---|---|---|---|---|
 | 26.53B | |||||
| 1,088B | |||||
| 629B | - | - | - | ||
| 440B | |||||
| 359B | |||||
| 291B |
- Stock Market
- Stocks
- 4503 Stock
- Charts Astellas Pharma Inc.
- Sector Chart
Select your edition
All financial news and data tailored to specific country editions
